Aclaris Therapeutics (ACRS) Stock: Buy, Sell, or Hold?
$4.24
+0.09 (+2.17%)
▲
5d:
+15.22%
30d:
+22.19%
90d:
-27.65%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$3.51 – $4.06
Position: EXTENDED
Forward P/E & Valuation
-5.9x
Next 12M consensus est.
Wall Street Target
$10.36
+149.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.45 / $4.30
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ACRS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ACRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACRS is currently trading at $4.24, which is considered extended relative to its 30-day fair value range of $3.51 to $4.06.
Technical Outlook: Technically, ACRS is in a strong downtrend. The price is approaching resistance at $4.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ACRS scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.36 (+149.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACRS is in a strong downtrend. The price is approaching resistance at $4.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ACRS scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.36 (+149.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.51 -
$4.06
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$3.51 -
$4.06
Current vs Trading Range
EXTENDED
Support Level
$3.45
Resistance Level
$4.30
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 149.7% below Wall St target ($10.36)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.86
Wall Street Target
$10.36
(+149.7%)
Revenue Growth (YoY)
-55.1%
Share ACRS Analysis
Share this live ACRS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACRS)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on $ACRS is increasing on StockTwits with no new news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:00 AM ET
Data refreshes hourly during market hours. Next update: 11:00 AM
Data refreshes hourly during market hours. Next update: 11:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 43 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACRS Research Pages
